Ed Kennedy's practice involves all aspects of federal and international taxation, including mergers and acquisitions, debt instruments and derivatives, foreign currency, Subpart F planning including contract manufacturing, cross-border structured finance, and distressed M&A. Ed works with strategic investors, private equity groups, and hedge funds to structure their investments in the most tax-efficient manner. He also works with large U.S.-based multinational corporations and foreign entities making inbound investments in the U.S., including investments in stock, securities, partnerships, and real estate. He is co-leader of the Firm's global Tax Practice.Ed worked on the federal and international tax aspects of the restructuring of both Dana Corporation and Chrysler LLC in chapter 11. Ed played a leading role in structuring Pfizer's $16.6 billion sale of its consumer health care business to Johnson & Johnson. He led the tax team that structured the $2.8 billion acquisition of the ConAgra commodities trading business by a consortium of private equity funds in 2008. Ed recently helped structure Pfizer's joint venture with GlaxoSmithKline to create a new HIV company.